Construction of a Metabolism-Related Long Non-Coding RNAs-Based Risk Score Model of Hepatocellular Carcinoma for Prognosis and Personalized Treatment Prediction
Background: Long non-coding RNAs (lncRNAs) play a key regulatory role in tumor metabolism. Although hepatocellular carcinoma (HCC) is a metabolic disease, there have been few systematic reports on the association between lncRNA expression and metabolism in HCC.Results: In this study, we screened 557...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book |
| Published: |
Frontiers Media S.A.,
2022-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_9ccd965a428b4c73a15d56cbf9dd9ea5 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Peichen Zhang |e author |
| 700 | 1 | 0 | |a Liping Chen |e author |
| 700 | 1 | 0 | |a Shengjie Wu |e author |
| 700 | 1 | 0 | |a Bailiang Ye |e author |
| 700 | 1 | 0 | |a Chao Chen |e author |
| 700 | 1 | 0 | |a Lingyan Shi |e author |
| 245 | 0 | 0 | |a Construction of a Metabolism-Related Long Non-Coding RNAs-Based Risk Score Model of Hepatocellular Carcinoma for Prognosis and Personalized Treatment Prediction |
| 260 | |b Frontiers Media S.A., |c 2022-05-01T00:00:00Z. | ||
| 500 | |a 1532-2807 | ||
| 500 | |a 10.3389/pore.2022.1610066 | ||
| 520 | |a Background: Long non-coding RNAs (lncRNAs) play a key regulatory role in tumor metabolism. Although hepatocellular carcinoma (HCC) is a metabolic disease, there have been few systematic reports on the association between lncRNA expression and metabolism in HCC.Results: In this study, we screened 557 metabolism-related lncRNAs in HCC. A risk score model based on 13 metabolism-related lncRNA pairs was constructed to predict the outcome and drug response in HCC. The risk score model presented a better prediction of the outcomes than that with common clinicopathological characteristics, such as tumor stage, grade, and status and aneuploidy score in both training and testing cohorts. In addition, patients in the high-risk group exhibited higher responses to gemcitabine and epothilone, whereas those in the low-risk group were more sensitive to metformin and nilotinib.Conclusion: The metabolism-related lncRNAs-based risk score model and the other findings of this study may be helpful for HCC prognosis and personalized treatment prediction. | ||
| 546 | |a EN | ||
| 690 | |a prognosis | ||
| 690 | |a lncRNA | ||
| 690 | |a hepatocellular carcinoma | ||
| 690 | |a metabolism | ||
| 690 | |a therapeutic response | ||
| 690 | |a Neoplasms. Tumors. Oncology. Including cancer and carcinogens | ||
| 690 | |a RC254-282 | ||
| 690 | |a Pathology | ||
| 690 | |a RB1-214 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Pathology and Oncology Research, Vol 28 (2022) | |
| 787 | 0 | |n https://www.por-journal.com/articles/10.3389/pore.2022.1610066/full | |
| 787 | 0 | |n https://doaj.org/toc/1532-2807 | |
| 856 | 4 | 1 | |u https://doaj.org/article/9ccd965a428b4c73a15d56cbf9dd9ea5 |z Connect to this object online. |